[Heparin therapy in pregnancy toxemia a parallelism of the therapy for consumption coagulopathy?].
D000030:Abortion, Missed / Q000150:complications; D000037:Abruptio Placentae / Q000150:complications; D000328:Adult; D001779:Blood Coagulation Factors / Q000032:analysis; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy / Q000209:etiology; D004487:Edema; D004619:Embolism, Amniotic Fluid / Q000150:complications; D005260:Female; D005313:Fetal Death / Q000150:complications; D005340:Fibrinogen / Q000032:analysis; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension; D011225:Pre-Eclampsia / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D011247:Pregnancy; D011507:Proteinuria; D011517:Prothrombin Time; D012772:Shock, Septic / Q000150:complications; D013921:Thrombocytopenia / Q000209:etiology
D001779:Blood Coagulation Factors; D005340:Fibrinogen; D006493:Heparin
Heparintherapie der EPH-Gestose Parallelität zur Therapie der Verbrauchskoagulopathie.